Literature DB >> 11169073

Aberrant expression of cytokeratin 7 as a histological marker of progression in primary biliary cirrhosis.

K Yabushita1, K Yamamoto, N Ibuki, N Okano, S Matsumura, R Okamoto, N Shimada, T Tsuji.   

Abstract

AIM: We evaluated the aberrant expression of cytokeratin 7 (CK-7) in hepatocytes as a marker of cholestasis and progression in primary biliary cirrhosis (PBC). PATIENTS AND METHODS: The expression of CK-7 was studied by immunohistochemistry in 83 cases of PBC. This expression was compared with biochemical data, the deposition of copper-associated protein, and previous histological classifications.
RESULTS: In normal liver, CK-7 was expressed exclusively in bile duct epithelial cells (BDE). In PBC, the expression was also observed in hepatocytes. The expression pattern was classified as follows: Grade 0, BDE as in normal; Grade 1, proliferated bile ductules; Grade 2, periportal hepatocytes in addition to proliferated bile ductules; Grade 3, intralobular hepatocytes; Grade 4, the majority of hepatocytes. The grades correlated with serum bilirubin levels but not with serum levels of biliary enzymes. A discrepancy between the CK-7 grading and Ludwig's classification was noted in cases with Stage 1 of the CK-7 grading who were considered Stage 2 or 3 in Ludwig's classification, suggesting that cholestasis and inflammatory activity might be independent events.
CONCLUSIONS: These results suggest that the aberrant expression of CK-7 in hepatocytes may be a marker of chronic cholestasis and progression in PBC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169073     DOI: 10.1034/j.1600-0676.2001.210108.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  7 in total

1.  Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis.

Authors:  Anna Lepistö; Sari Kivistö; Leena Kivisaari; Johanna Arola; Heikki J Järvinen
Journal:  Int J Colorectal Dis       Date:  2009-07-28       Impact factor: 2.571

2.  If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.

Authors:  Kari Nejak-Bowen
Journal:  Gene Expr       Date:  2019-08-22

3.  Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results.

Authors:  Helmut Denk; Daniela Pabst; Peter M Abuja; Robert Reihs; Brigitte Tessaro; Kurt Zatloukal; Carolin Lackner
Journal:  Mod Pathol       Date:  2021-10-13       Impact factor: 7.842

4.  Simultaneous segmental obstruction of bile duct and portal vein markedly changes a population of biliary and hepatic cells in human liver.

Authors:  Takanori Kyokane; Masato Nagino; Junichi Kamiya; Yuji Nimura; Tetsuro Nagasaka
Journal:  Langenbecks Arch Surg       Date:  2003-05-16       Impact factor: 3.445

5.  Chronic cholestasis detection by a novel tool: automated analysis of cytokeratin 7-stained liver specimens.

Authors:  Martti Färkkilä; Johanna Arola; Nelli Sjöblom; Sonja Boyd; Anniina Manninen; Anna Knuuttila; Sami Blom
Journal:  Diagn Pathol       Date:  2021-05-06       Impact factor: 2.644

6.  Expression of vascular endothelial growth factor A in liver tissues of infants with biliary atresia.

Authors:  Alif Allam; Mohammed El-Guindi; Hatem Konsowa; Dina El Azab; Maha Allam; Tahany Salem; Haidy Mohammed Zakaria
Journal:  Clin Exp Hepatol       Date:  2019-11-08

7.  Keratin 7 expression in hepatic cholestatic diseases.

Authors:  S Sakellariou; C Michaelides; T Voulgaris; J Vlachogiannakos; E Manesis; D G Tiniakos; I Delladetsima
Journal:  Virchows Arch       Date:  2021-07-27       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.